Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 7SL, cytoplasmic 288, pseudogene (RN7SL288P), is a pseudogene in the human genome, related in sequence to the 7SL RNA (signal recognition particle RNA). 7SL RNA is an essential non-coding RNA component of the signal recognition particle (SRP), which directs nascent proteins to the endoplasmic reticulum during translation. RN7SL288P, however, is one of many dispersed truncated copies generated by reverse transcription events of 7SL RNA and does not encode a functional RNA or protein product. While most 7SL pseudogenes are considered transcriptionally inactive, some pseudogenes in general can exert post-transcriptional regulatory effects by acting as decoys or regulatory RNAs; specific regulatory function for RN7SL288P has not been described.
Not applicable, as this is not a functional protein or a drug target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 288, pseudogene (RN7SL288P).